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ABSTRACT
Five different antibiotic susceptibility methods were utilized to test the effectiveness of cefotetan
against 200 anaerobic bacteria recovered from patients with obstetrical or gynecological infections.
The object of this study was to determine if a more economical and rapid method for anaerobic
susceptibility testing was as acceptable as the reference agar dilution method. The five methods
were: 1) broth disk elution, 2) microbroth technique, 3) a commercially available microbroth tech-
nique, 4) a commercially available spiral gradient technique, and 5) reference agar dilution. The
minimal inhibitory concentrations (MICs) calculated from the spiral gradient technique were equal
to or within one doubling dilution of the reference system in 99.5% of cases, while the percentage for
the commercially available microbroth system was 96.8%, very similar to the microbroth technique
used in our laboratory that yielded a percentage of 96.3. The disk elution method correlated to the
reference agar dilution method in 95.3% cases. While the overall agreement between these tech-
niques is good, especially for the spiral gradient system, clustering of certain organisms near the
breakpoint ofthe antibiotic tested results in variability in the labeling of these organisms as suscepti-
ble or resistant. This problem appears to be particularly significant for the disk elution method.
Therefore, further refinements in these methods of susceptibility testing are needed in order to
provide a more clinically useful assessment of the susceptibility or resistance of certain bacterial
isolates. (C) 1993 Wiley-Liss, Inc.
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ost soft tissue pelvic infections in obstetrics
and gynecology are polymicrobial, with
anaerobic bacteria often playing a significant role.
Treatment of these infections is empiric and re-
quires a broad-spectrum antimicrobial agent. Beta-
lactam antibiotics, which have a broad spectrum of
activity including aerobic, facultative, and obligate
anaerobes, are suitable for the treatment of obstetric
and gynecologic infections, e.g., postpartum en-
dometritis, pelvic inflammatory disease, and pelvic
cellulitis. Cefotetan, a 7-methoxy beta-lactam anti-
biotic, with a long serum half-life and a broad
spectrum ofactivity,
1,2 is considered suitable for the
empiric treatment of ob/gyn infections.
Concerns have been raised about the apparent
variability in in vitro activity of certain beta-lactam
antibiotics against anaerobic organisms. 3’4 There-
fore, cefotetan was tested against anaerobic organ-
isms isolated from patients with gynecologic or ob-
stetrical soft tissue pelvic infections using five
different antibiotic susceptibility testing methods,
as described by the National Committee for Clini-
cal Laboratory Standards (NCCLS). s’6 This was
done in order to determine if a more economical or
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rapid method for anaerobic sensitivity testing was
as acceptable as the reference agar dilution method.
MATERIALS AND METHODS
The bacteria tested were isolated from patients who
were treated for obstetrical or gynecologic pelvic
infections. The organisms were frozen at -70C
after being isolated and identified as described pre-
viously.
7 The bacteria were passed twice on solid
media before being used for testing. The reference
agar dilution testing was performed according to
the NCCLS published method, s All media were
prepared in the laboratory and pre-reduced shortly
after preparation. The broth disk dilution method
was performed using thioglycolate broth according
to the method described by the NCCLS.
6 Like-
wise, the microbroth method using pre-reduced
Wilkins-Chalgren broth was performed according
to the NCCLS publication.
6 The Sceptor system
(BBL, Cockeysville, MD) was used to test a com-
mercially available microbroth system. Broth cul-
tures of the isolates were adjusted to a turbidity
equivalent of 0.5 MacFarland standard. One hun-
dred microliters of this broth was added to 10 ml of
pre-reduced Sceptor anaerobes minimal inhibitory
concentration (MIC)-ID broth and vortexed. One
hundred microliters per well of this Sceptor broth
was then added to each of 84 wells in the Sceptor
MIC panel and incubated in an anaerobic chamber
for 48 hours at 36C. The Spiral system was used
according to the instructions of Spiral System In-
struments Inc. (Bethesda, MD). Antibiotic gradi-
ents were made using the spiral platter on pre-
reduced Wilkins-Chalgren agar. Sixty milliliters
of agar were poured into 150 ml Petri dishes
achieving an agar depth of 3.3 mm. The plates
were allowed to sit in an anaerobic environment for
hour before inoculation. Broth cultures (BHI
plus vitamin K and hemin) of the isolates were
adjusted to a turbidity equivalent to a 0.5 MacFar-
land. A sterile Dacron swab was used to plate the
isolates on the gradient plates. A spiral system tem-
plate aided in the placement of 15 isolates for each
gradient plate. Wilkins-Chalgren plates without
drug were also inoculated as growth control. Plates
were incubated for 48 hours at 36C in an anaero-
bic chamber. Interpretation of the gradient plate
results involved a measure in the length of each
isolate using the spiral system template. The MIC
values were calculated using the spiral gradient
endpoint software. Bacteroidesfragilis ATCC2 52 8 5
was used as a control for all MIC procedures. This
organism was tested with these systems to ensure
that the MICs were within an acceptable range.
Detailed descriptions of the methods can be found
in the referenced NCCLS publications. 5’6 Ce-
fotetan was provided by Stuart Pharmaceuticals
(Wilmington, DE).
RESULTS
Table summarizes the in vitro activity of ce-
fotetan against the various anaerobes tested as deter-
mined by the five different methods. Bacteroides
capillosus, B. distasonis, B. thetaiotamicron, and Pre-
votella ruminicola have relative resistance to ce-
fotetan. The majority of organisms, mainly Por-
phyromonas asaccharolyticus, P. bivius, P.
intermedius, P. melaninogenicus, P. oralis, B. vulga-
tus, B. fragilis, Fusobacterium, and Peptostreptococ-
cus sp. are susceptible to cefotetan.
With respect to the agar dilution method, the
commercial spiral system identified MICs equal to
or within one doubling dilution of the reference
system in 99.5% of tested organisms. The commer-
cial microbroth system identified 96.8% of MICs,
while the microtube dilution identified 96.3% of
MICs as equal to or within one doubling dilution
of the reference system. The disk elution method
breakpoint was in agreement with the susceptible or
resistant determinations of the agar dilution refer-
ence method in 95.3% of cases. However, among
the 17 strains that were identified as resistant to
cefotetan by agar dilution, the disk dilution tech-
nique identified correctly as resistant only 8 isolates
(47% agreement). Of the nine isolates that were
identified as resistant with the agar dilution method
and as susceptible by the disk elution technique,
eight were at the breakpoint. The spiral gradient
technique identified six isolates (65% agreement) as
susceptible to cefotetan that the reference agar dilu-
tion classified as resistant. The MICs for six of
these isolates were of 64 Ixg/ml by agar dilution,
and 32 bg/ml by the spiral gradient technique.
Similar results were obtained with the commer-
cially available microbroth system (71% agree-
ment) and with the laboratory developed micro-
broth system (65% agreement). In all cases, the
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TABLE I. MIC90 and number of resistant isolates as identified by five different methods
Organism Agar dilution Spiral
(no. of strains) No. MICgo No. MICgo
Method
Sceptor
microbroth
No. MIC9o
Laboratory Disk
microbroth elution
No. MICgo No.
Porphyromonas asaccharolyticus (8) 0 32 0 16 0 16 0 16 0
Prevotella bivius (80) 32 32 32 32 0
Bacteroides fragilis (22) 3 64 2 16 2 16 2 16 2
P. intermedius (8) 0 32 0 16 0 16 0 16
P. melaninogenicus (18) 64 0 32 64 0 32 0
P. oralis (4) 0 16 0 16 0 16 0 16 0
B. vulgatus (3) 0 32 0 16 0 16 0 16 0
B. capillosus (12) 6 128 3 128 3 128 3 64 2
B. distasonis (3) 2 64 2 64 2 64 2 64 2
B. thetaiotamicron (I) 128 128 128 128
P. ruminicola (5) 2 128 2 128 2 128 2 128
Fusobacterium sp. (7) 0 8 0 8 0 4 0 4 0
Peptostreptococcus sp. (29) 16 0 8 0 8 0 4 0
aNumber of resistant isolates (MIC 64 Ig/ml). Minimal concentration to inhibit 90% growth (MICg0) is Ig/ml.
MICs were higher by the agar dilution method
than the other techniques.
DISCUSSION
While the role of anaerobic bacteria in the patho-
genesis of infections in obstetrics and gynecology is
well established, the need for susceptibility testing
of anaerobic organisms against antimicrobial agents
is still subject to some controversy.
8 Initial antibi-
otic therapy of female pelvic soft tissue polymicro-
bial infections is empiric. Therefore, it is impor-
tant to identify antimicrobial agents that have the
necessary spectrum of activity to ensure adequate
coverage of the suspected pathogens and to follow
susceptibility patterns of anaerobes as different an-
timicrobial agents are used. Unfortunately, the sus-
ceptibility testing of antimicrobial agents against
anaerobic organisms using the agar dilution
method is technically complex and time consum-
ing. Several alternative methods have, therefore,
been proposed with the aim of reducing the cost in
terms of time and material that such testing de-
mands. Unfortunately, the use of different suscep-
tibility testing methods has revealed the difficulty
of standardizing different tests (or even the same
test) among different laboratories. From our data,
it appears that the spiral system, the microbroth,
and the commercially available microbroth system
are adequate methods to evaluate anaerobic suscep-
tibility to cefotetan. The broth disk elution method
did not provide the same degree of reliability as the
other methods tested.
A recent report comparing the spiral gradient
technique and the conventional agar dilution
method concluded that the spiral technique is a
reasonable alternative.
9 The data presented here
confirm that the spiral method is as reliable as the
reference method and in our laboratory was less
tedious to use. We confirmed the report that the
commercial broth microdilution system gives
MICs lower than those of the agar dilution sys-
10 tern.
The results published from other studies using
the broth disk elution technique are consistent with
our experience.
11 The broth disk elution method is
inadequate for the clinical evaluation of susceptibil-
ity of anaerobic organisms and has recently been
eliminated as an approved method by the NC-
CLSo
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In conclusion, we believe that anaerobic suscep-
tibility testing should be performed in major med-
ical centers both to monitor the changing pattern.of
antibiotic susceptibility and to help in the manage-
ment of clinically difficult cases. In our experience,
the use of a less labor-intensive method may be an
acceptable alternative if further refinements in the
techniques will reduce the difficulties in the correct
interpretation of MICs occurring near the break-
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point when anaerobic organisms are tested against
cefotetan or other beta-lactam antibiotics. Close
correlation of the in vitro results with the results of
clinical therapy is obviously necessary to confirm
the validity of in vitro testing of anaerobic bacteria
as a tool toward better treatment of actual clinical
cases.
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